New Enterprise Associates
http://www.nea.com/Home/New Enterprise Associates is a venture capital firm based in Baltimore, MD. The firm has backed more than 160 companies that have gone public and invested in more than 230 companies that have been successfully merged or acquired. NEA focuses its investments in the information technology, healthcare, and energy technology industries. While NEA makes a majority of its investments in the United States, the firm invests around the world in China and India. The firm was founded in 1978.
View Older Stories View More Recent Stories
-
CIT GAP Funds Invests in NOVI to Further the Development of Small Satellite Market
-
Dr. Ross Jaffe, MD Joins NEA As Venture Advisor
-
Databricks Appoints Public Sector Leader to Meet Demand for Unified Analytics
-
Fugue Named One of Maryland's Best Tech Startups
-
MotoAmerica Announces Live+ Streaming For 2019
-
Ascletis and 3-V Biosciences Announce NASH Strategic License and Series E Financing
-
Ascletis and 3-V Biosciences Announce NASH Strategic License and Series E Financing
-
Form SC 13G Bloom Energy Corp Filed by: NEW ENTERPRISE ASSOCIATES 10 L P
-
Form SC 13G Surface Oncology, Inc. Filed by: New Enterprise Associates 14, L.P.
-
Form SC 13G Elastic N.V. Filed by: New Enterprise Associates 14, L.P.
-
Form SC 13G/A Clementia Pharmaceutical Filed by: New Enterprise Associates 15, L.P.
-
Alan M. Muney, MD, MHA Joins NEA As Venture Advisor
-
Ascletis and 3-V Biosciences Announce NASH Strategic License and Series E Financing
-
Form SC 13G/A APPIAN CORP Filed by: New Enterprise Associates 14, L.P.
-
Form SC 13G/A CRISPR Therapeutics AG Filed by: New Enterprise Associates 15, L.P.
-
CIT GAP Funds Invests in DroneUp to Revolutionize Commercial Drone Pilot Services
-
Topia Taps Shawn Farshchi as New CEO to Lead Next Phase of Growth for Global Mobility Management Company
-
Databricks’ $250 Million Funding Supports Explosive Growth and Global Demand for Unified Analytics; Brings Valuation to $2.75 Billion
-
TCI Marketing Services Launches TCInsights Reporting Dashboards
-
Global Health Care Leaders Back Aetion with $27 Million Strategic Investment
-
Catalytic, Inc Raises $30 Million in Series B Funding Led by Intel Capital
-
OmniSci Experiences Hypergrowth as Market Demand for GPU-accelerated Analytics Rises
-
Form SC 13D/A TESARO, Inc. Filed by: NEW ENTERPRISE ASSOCIATES 13 LP
-
Timescale Raises Additional $15 Million and Introduces Enterprise Offering to Accelerate Growth of its SQL Time-Series Database
-
Building on Customer Traction, Gladly Closes $50M to Reinvent Customer Service by Putting People at the Center of Every Conversation
-
Feedzai and DataRobot Partner to Help Banks Fight Financial Crime with Advanced Machine Learning
-
Knotch Raises $20 Million in Series B Funding to Power Continued Innovation and International Expansion
-
Topia Promotes Elaine Foreman to Role of General Counsel
-
PlacementTracker Publishes 2018 PIPE and Private Placement Markets League Tables
-
KDT Leads $160 Million Investment in Desktop Metal to Drive the Adoption of the Company’s Metal 3D Printers for Mass Production and the World’s First Office-Friendly Metal 3D Printing System
-
Spring Mountain Capital Completes Successful Exit of Activate Healthcare
-
Brexit Uncertainty Doesn't Faze this US Company
-
OmniSci Hires Ray Falcione Jr. as Vice President of U.S. Federal Business
-
Paladina Health Acquires Activate Healthcare to Amplify Impact of Primary Care Nationwide
-
StreamSets Extends DataOps to Snowflake
-
Echo Health Ventures Joins Strive Health’s Investor Group to Help Transform Kidney Care for Patients
-
Echo Health Ventures Joins Strive Health’s Investor Group to Help Transform Kidney Care for Patients
-
Black Diamond Therapeutics Closes $85 Million Series B Financing
-
ViewLift Announces Video Streaming Alliance
-
Cydan Announces Formation of Tiburio Therapeutics Inc. to Develop Treatments for Rare Neuroendocrine Tumors and Endocrine Diseases
-
Form 3 Nightstar Therapeutics For: Jan 01 Filed by: New Enterprise Associates 15, L.P.
-
Form 4 AVEO PHARMACEUTICALS For: Dec 20 Filed by: New Enterprise Associates 15, L.P.
-
Form SC 13D/A Ra Pharmaceuticals, Inc. Filed by: NEW ENTERPRISE ASSOCIATES 13 LP
-
Form SC 13D Millendo Therapeutics, Filed by: New Enterprise Associates 15, L.P.
-
Topia Earns Brandon Hall Award, Rides Wave of Momentum Into 2019 with Customer Wins, New Brand & Product Expansion
-
OrphoMed Announces Formation of Scientific Advisory Board
-
Automation Anywhere and DataRobot Partner on AI Solutions for Digital Transformation
-
Topia CEO Brynne Kennedy Named 2018 CloudNOW Top Woman in Cloud Innovation
-
Millendo Therapeutics Announces Successful Merger Completion
-
Form SC 13D/A TESARO, Inc. Filed by: NEW ENTERPRISE ASSOCIATES 13 LP

